observ
studi
report
associ
underli
cardiovascular
diseas
cvd
wors
prognosi
patient
still
remain
unclear
conduct
metaanalysi
recent
studi
report
associ
cvd
wors
prognosi
increas
mortal
patient
literatur
search
pubm
cochran
librari
embas
complet
review
novemb
april
inclus
criteria
observ
casecontrol
cohort
studi
patient
histori
cvd
includ
report
outcom
infect
sever
clearli
outlin
definit
sever
diseas
sampl
size
data
abstract
independ
author
studi
divid
two
separ
cohort
analysi
sever
sever
vs
nonsever
mortal
nonsurvivor
vs
survivor
data
pool
metaanalysi
estim
pool
odd
ratio
confid
interv
ci
outcom
total
studi
n
patient
includ
sixteen
studi
china
unit
state
preexist
cvd
associ
significantli
increas
risk
sever
form
ci
q
overal
risk
allcaus
mortal
ci
howev
studi
find
signific
associ
previou
histori
cvd
mortal
sever
diseas
ci
preexist
cvd
associ
wors
outcom
among
patient
clinician
policymak
need
take
account
find
implement
risk
stratif
model
ongo
pandem
coronaviru
diseas
covid
associ
high
rate
morbid
mortal
clinic
biolog
predictor
need
identifi
sever
infect
help
judici
alloc
limit
resourc
cardiovascular
diseas
cvd
lead
caus
morbid
mortal
unit
state
also
associ
wors
outcom
patient
influenza
bacteri
pneumonia
emerg
data
link
presenc
cvd
wors
prognosi
patient
likewis
associ
high
inflammatori
induc
vascular
inflamm
myocard
cardiac
arrhythmia
turn
aggrav
damag
heart
howev
scatter
studi
wide
vari
result
publish
far
small
sampl
size
patient
previou
cvd
histori
studi
limit
applic
thu
aim
compil
analys
result
recent
publish
influenc
cvd
sever
infect
end
carri
pool
analysi
current
studi
evalu
associ
underli
previou
histori
cvd
condit
outcom
infect
sever
patient
systemat
review
metaanalysi
conduct
strict
conform
prefer
report
item
systemat
review
metaanalys
prisma
guidelin
protocol
studi
report
intern
prospect
regist
systemat
review
prospero
identifi
comprehens
systemat
search
literatur
novemb
april
conduct
electron
databas
pubm
embas
cochran
central
regist
control
trial
central
identifi
studi
elig
inclus
electron
search
carri
use
strategi
follow
coronaviru
diseas
cardiovascular
diseas
coronari
arteri
diseas
hypertens
languag
restrict
made
articl
publish
studi
group
overlap
search
period
recent
articl
includ
avoid
duplic
data
pubm
function
relat
articl
use
extend
search
also
search
major
infecti
diseas
cardiovascular
gener
medicin
journal
report
articl
infect
look
addit
studi
perform
handsearch
bibliographi
includ
studi
detect
potenti
elig
investig
studi
screen
assess
elig
four
independ
review
ga
death
cardiovascular
diseas
defin
cardiac
patholog
except
hypertens
review
studi
incomplet
irrelev
data
exclud
disagr
review
aris
elig
assess
settl
consensu
studi
follow
inform
extract
surnam
first
author
year
public
geograph
region
studi
perform
type
studi
cohort
casecontrol
sampl
size
baselin
demograph
characterist
proport
patient
sever
nonsever
proport
patient
underli
cvd
mortal
varianc
resolv
consensu
qualiti
assess
analysi
risk
bia
select
fulltext
articl
perform
use
newcastleottawa
scale
no
nonrandom
studi
primari
outcom
interest
associ
preexist
cvd
sever
secondari
outcom
associ
underli
cvd
mortal
tertiari
outcom
associ
underli
cvd
mortal
patient
sever
diseas
thu
total
three
separ
metaanalys
perform
statist
analysi
carri
use
metaxl
softwar
version
epigear
intern
pti
ltd
sunris
beach
australia
comprehens
metaanalysi
softwar
version
biostat
new
jersey
unit
state
strength
associ
preexist
cvd
sever
mortal
estim
use
odd
ratio
randomeffect
model
dersimonian
laird
appli
due
heterogen
definit
cvd
amongst
studi
magnitud
heterogen
among
includ
studi
assess
use
chisquar
test
chi
isquar
statist
chi
test
cochran
q
p
valu
consid
signific
valu
statist
interpret
follow
confid
interv
might
import
might
indic
moder
heterogen
may
repres
substanti
heterogen
may
repres
signific
heterogen
subgroup
use
compar
cohort
vs
casecontrol
studi
public
bia
assess
funnel
plot
analysi
random
effect
metaregress
use
log
perform
evalu
impact
baselin
characterist
age
sex
associ
cvd
diseas
sever
patient
addit
leaveon
sensit
analysi
perform
assess
robust
result
probe
sourc
interstudi
heterogen
initi
search
produc
potenti
relev
articl
follow
remov
duplic
primari
screen
articl
assess
full
text
elig
metaanalysi
exclud
primari
secondari
outcom
studi
match
review
thu
total
articl
includ
systemat
review
metaanalysi
figur
tabl
total
studi
report
data
associ
preexist
cvd
sever
pool
analysi
cvd
found
associ
significantli
increas
risk
sever
form
casecontrol
ci
q
p
cohort
studi
ci
q
p
overal
analysi
reveal
low
evid
interstudi
heterogen
cochran
q
signific
chang
seen
leaveoneout
sensit
analysi
figur
supplementari
materi
diseas
total
three
n
studi
report
data
mortal
patient
sever
diseas
preexist
histori
cvd
pool
analysi
studi
find
signific
associ
previou
histori
cvd
mortal
sever
diseas
ci
cochran
heterogen
seen
among
studi
figur
supplementari
materi
total
n
studi
report
data
mortal
hospit
patient
diseas
preexist
histori
cvd
pool
analysi
previou
histori
cvd
associ
increas
mortal
ci
moder
level
interstudi
heterogen
cochran
q
signific
differ
note
leaveoneout
sensit
analysi
figur
supplementari
materi
potenti
public
bia
evalu
funnel
plot
supplementari
materi
mild
asymmetri
note
funnel
plot
cvd
sever
limit
studi
mortal
analys
limit
determin
potenti
public
bia
studi
importantli
metaregress
odd
sever
diseas
underli
cvd
age
patient
sever
group
signific
influenc
calcul
pool
odd
ratio
howev
interestingli
women
sever
group
increas
odd
ratio
sever
diseas
cvd
associ
result
demonstr
underli
previou
histori
cvd
directli
associ
wors
prognosi
sever
outcom
patient
cvd
found
associ
around
increas
odd
sever
infect
increas
allcaus
mortal
among
patient
sever
possibl
explan
find
first
coexist
may
consider
enhanc
sever
underli
cvd
alreadi
proven
respiratori
infect
symptomatolog
fever
cough
imag
find
may
divert
clinician
attent
away
possibl
cardiovascular
injuri
patient
confirm
sever
drug
current
use
treat
infect
shown
deleteri
cardiovascular
effect
chloroquinehydroxychloroquin
azithromycin
associ
prolong
qtc
interv
risk
arrhythmia
conduct
defect
ventricular
arrhythmia
heart
failur
report
azithromycin
remdesivir
therapi
lopinavirritonavir
interleukin
therapi
shown
associ
ischem
heart
diseas
abnorm
lipid
profil
last
least
patient
deem
either
rel
stabl
guard
prognosi
may
consid
invas
strategi
preserv
healthcar
resourc
prevent
spread
infect
studi
sever
limit
first
sinc
studi
wuhan
china
potenti
overlap
one
patient
could
includ
one
studi
high
found
limit
number
studi
rel
small
sampl
size
literatur
search
howev
stage
ongo
pandem
find
may
provid
earli
insight
build
model
risk
stratif
help
judici
use
limit
healthcar
resourc
care
evalu
patient
perform
order
avoid
overlap
studi
use
exclus
criteria
due
small
number
studi
sensit
public
bia
analys
perform
assess
heterogen
sinc
age
sex
signific
confound
variabl
perform
metaregress
assess
impact
mean
age
diseas
sever
mortal
patient
larger
studi
need
confirm
find
conclud
presenc
cvd
found
associ
sever
mortal
howev
larger
studi
need
confirm
find
individu
previou
histori
cvd
especi
older
individu
comorbid
awar
develop
relat
symptom
fever
cough
dyspnea
previous
expos
person
known
suspect
infect
immedi
refer
healthcar
servic
receiv
specif
health
safeti
advic
time
manag
prevent
worsen
clinic
condit
final
gener
popul
strongli
avoid
contact
peopl
higher
risk
sever
ill
underli
cvd
author
relev
affili
financi
involv
organ
entiti
financi
interest
financi
conflict
subject
matter
materi
discuss
manuscript
includ
employ
consult
honoraria
stock
ownership
option
expert
testimoni
grant
patent
receiv
pend
royalti
